.
.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted.
.
researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
.